Antibiotic exposure in infancy may boost Type 1 diabetes risk, reveals research

Exposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin– producing cells in the pancreas and may boost risk of diabetes later in life, new research in mice suggests.

The study, published this month in the journal Science, also pinpoints specific microorganisms that may help those critical cells proliferate in early life.

The findings are the latest to shine a light on the importance of the human infant microbiome-the constellation of bacteria and fungi living on and in us during our first few years. The research could lead to new approaches for addressing a host of metabolic diseases.

“We hope our study provides more awareness for how important the infant microbiome actually is for shaping development,” said first author Jennifer Hill, assistant professor in molecular, cellular and developmental biology at CU’s BioFrontiers Institute. “This work also provides important new evidence that microbe-based approaches could someday be used to not only prevent but also reverse diabetes.”

Something in the environment

More than 2 million U.S. adults live with Type 1 diabetes, an incurable disease in which the pancreas fails to make insulin (the hormone that turns glucose into energy) and the blood fills with sugar.

The disease typically emerges in childhood, and genetics play a strong role. But scientists have found that, while identical twins share DNA that predisposes them to Type 1 diabetes, only one twin usually gets the disease.

“This tells you that there’s something about their environmental experiences that is changing their susceptibility,” said Hill.

For years, she has looked to microbes for answers.

Previous studies show that children who are breastfed or born vaginally, which can both promote a healthy infant microbiome, are less likely to develop Type 1 diabetes than others. Some research also shows that giving babies antibiotics early can inadvertently kill good bugs with bad and boost diabetes risk.

The lingering questions: What microbes are these infants missing out on?

“Our study identifies a critical window in early life when specific microbes are necessary to promote pancreatic cell development,” said Hill.

A key window of opportunity

She explained that human babies are born with a small amount of pancreatic “beta cells,” the only cells in the body that produce insulin.

But some time in a baby’s first year, a once-in-a-lifetime surge in beta cell growth occurs.

“If, for whatever reason, we don’t undergo this event of expansion and proliferation, that can be a cause of diabetes,” Hill said.

She conducted the current study as a postdoctoral researcher at the University of Utah with senior author June Round, a professor of pathology.

They found that when they gave broad-spectrum antibiotics to mice during a specific window (the human equivalent of about 7 to 12 months of life), the mice developed fewer insulin producing cells, higher blood sugar levels, lower insulin levels and generally worse metabolic function in adulthood.

“This, to me, was shocking and a bit scary,” said Round. “It showed how important the microbiota is during this very short early period of development.”

Lessons in baby poop

In other experiments, the scientists gave specific microbes to mice, and found that several they increased their production of beta cells and boosted insulin levels in the blood.

The most powerful was a fungus called Candida dubliniensis.

The team used fecal samples from The Environmental Determinants of Diabetes in the Young (TEDDY) study to make what Hill calls “poop slushies” and fed them to the mice.

When the researchers inoculated newborn mice with poop from healthy infants between 7 to 12 months in age, their beta cells began to grow. Poop from infants of other ages did not do the same.

Notably, Candida dublineinsis was abundant in human babies only during this time period.

“This suggests that humans also have a narrow window of colonization by these beta cell promoting microbes,” said Hill.

When male mice that were genetically predisposed to Type 1 diabetes were colonized with the fungus in infancy, they developed diabetes less than 15% of the time. Males that didn’t receive the fungus got diabetes 90% of the time.

Even more promising, when researchers gave the fungus to adult mice whose insulin-producing cells had been killed off, those cells regenerated.

Too early for treatments

Hill stresses that she is not “anti-antibiotics.”

But she does imagine a day when doctors could give microbe-based drugs or supplements alongside antibiotics to replace the metabolism-supporting bugs they inadvertently kill.

Poop slushies (fecal microbiota transplants) have already been used experimentally to try to improve metabolic profiles of people with Type 2 diabetes, which can also damage pancreatic beta cells.

But such approaches can come with real risk, since many microbes that are beneficial in childhood can cause harm in adults. Instead, she hopes that scientists can someday harness the specific mechanisms the microbes use to develop novel treatments for healing a damaged pancreas—reversing diabetes.

She recently helped establish a state-of-the-art “germ-free” facility for studying the infant microbiome at CU Boulder. There, animals can be bred and raised in sterile “bubbles” entirely without microbes, and by re-introducing them one by one scientists can learn they work.

“Historically we have interpreted germs as something we want to avoid, but we probably have way more beneficial microbes than pathogens,” she said. “By harnessing their power, we can do a lot to benefit human health.”

Reference:

Jennifer Hampton Hill et al. ,Neonatal fungi promote lifelong metabolic health through macrophage-dependent β cell development.Science387,eadn0953(2025).DOI:10.1126/science.adn0953

Powered by WPeMatico

Surgery Provide Early Benefits Among Patients with Humeral Shaft Fractures: JAMA

UK: A recent randomized clinical trial compared operative and nonoperative management of humeral shaft fractures, shedding light on their benefits and risks. The findings were published online in JAMA Surgery on March 26, 2025.

The researchers found that surgery provided early functional advantages over bracing for patients with humeral shaft fractures. However, these benefits must be weighed against operative risks, as there was no significant difference in outcomes at 1 year between surgical and non-surgical treatments.

Humeral shaft fractures are commonly treated without surgery, but this approach may lead to higher rates of nonunion and potentially poorer functional outcomes compared to operative fixation. Given these concerns, evaluating the effectiveness of surgical intervention versus nonoperative management using functional bracing becomes crucial. Understanding whether surgery offers significant advantages in terms of healing, mobility, and overall recovery can help guide treatment decisions.

Against the above background, William M. Oliver, Edinburgh Orthopaedics, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom, and colleagues aimed to determine if there is a meaningful difference in outcomes between the two approaches for adults with isolated, closed humeral shaft fractures, providing valuable insights into the most effective management strategy.

For this purpose, the researchers conducted a prospective, superiority, parallel-group, randomized clinical trial at a major trauma center in the UK between September 2018 and October 2023. The study included 70 adults with isolated, closed humeral shaft fractures, excluding those with absolute surgical indications, pathological or periprosthetic fractures, multiple traumas, significant frailty, or follow-up constraints. Patients were randomized to open reduction and plate fixation (n=36) or functional bracing (n=34), with seven not receiving the assigned treatment.

The primary outcome was the DASH score at three months, while secondary outcomes included quality of life, pain, joint mobility, and complications.

The key findings of the study were as follows:

  • The study included 70 patients with a mean age of 49, comprising 38 females (54%) and 32 males (46%).
  • At three months, 66 patients (94%) had completed follow-up.
  • The operative group showed a significantly better DASH score at three months (difference: 15.0) and six weeks (difference: 14.7), but not at six months or twelve months.
  • Surgery was associated with higher EQ-5D scores at six weeks (difference: 0.126).
  • At six months, the EQ-VAS score was higher in the operative group (difference: 7).
  • SF-12 MCS scores favored surgery at six weeks (difference: 9.3), three months (difference: 6.9), and six months (difference: 7.1).
  • Brace-related dermatitis was more common in the nonoperative group (18% vs. 3%).
  • Nonunion occurred in 11% of cases, with a higher rate in the nonoperative group (18% vs. 6%).

The study demonstrated that surgical management of isolated closed humeral shaft fractures offered early functional benefits, including enhanced upper-limb function, improved quality of life, pain relief, and better range of motion. However, the researchers observed that these advantages diminished beyond six months, with no significant differences in patient-reported outcomes at one year.

“Given the potential risks of surgery, these short-term gains should be carefully weighed against operative complications. Identifying patients at a higher risk of nonunion and considering early surgical intervention in select cases may offer the most appropriate treatment approach,” the authors concluded.

Reference:

Oliver WM, Bell KR, Carter TH, et al. Operative vs Nonoperative Management of Fractures of the Humeral Diaphysis: The Humeral Shaft Fracture Fixation Randomized Clinical Trial. JAMA Surg. Published online March 26, 2025. doi:10.1001/jamasurg.2025.0301

Powered by WPeMatico

Malocclusion Impact Questionnaire useful Tool for Assessing Malocclusion Impact on OHRQoL: Study

Researchers have found in a new research that malocclusion Impact Questionnaire is useful Tool for Assessing Malocclusion Impact on OHRQoL.The study highlights the effectiveness of the Malocclusion Impact Questionnaire (MIQ) in evaluating the impact of malocclusion on Oral Health-Related Quality of Life (OHRQoL) in orthodontics. The differences in OHRQoL between children with and without severe hypodontia (missing ≥5 teeth) were minimal. Delaying treatment until the patient expresses a subjective need may help prevent unnecessary treatments in children with hypodontia.

A study was done to assess the impact of malocclusion on oral health-related quality of life (OHRQoL) and to compare the impact of malocclusion in children with and without hypodontia. Children aged 10-16 years with ≥ 5 missing teeth and without hypodontia completed the Malocclusion Impact Questionnaire (MIQ) to assess the impact of malocclusion on OHRQoL. The Child Perception Questionnaire 11-14 years short form (CPQ11-14-ISF16) was used to verify the validity of the MIQ. Demographic and orthodontic data were collected. Internal consistency and validity of the MIQ were analyzed. MIQ scores were compared using an independent t‑test. Regression analysis was performed to identify predictors of the MIQ score. RESULTS: A total of 92 participants completed the MIQ, and 52 participants the CPQ11-14-ISF16. The MIQ showed excellent internal consistency (Cronbach’s α 0.89) and good criterion validity with CPQ11-14-ISF16 (r = 0.58). No significant difference in the impact of malocclusion on OHRQoL between the groups (p = 0.15) was found. Age (p < 0.05), sex (p < 0.001), and general appearance (p < 0.001) significantly predicted OHRQoL scores in the regression analysis. Multilevel analysis showed that the group and age effects were nonsignificant and that sex and general appearance were predictive for the MIQ score. This study suggests that the MIQ is a useful tool to assess the impact of malocclusion on OHRQoL in the orthodontic field. Differences in the impact of malocclusion on OHRQoL between children with and without hypodontia of ≥ 5 teeth were limited. It may be beneficial delaying treatment until the patient expresses a subjective treatment need which may reduce overtreatment of children with hypodontia.

Reference:

Duisterwinkel, Farnaz, et al. “Impact of Malocclusion On Oral Health-related Quality of Life: Insights From Children With and Without Hypodontia.” Journal of Orofacial Orthopedics = Fortschritte Der Kieferorthopadie : Organ/official Journal Deutsche Gesellschaft Fur Kieferorthopadie, 2025.

Keywords:

Malocclusion, Impact, Questionnaire, useful, Tool, Assessing, Malocclusion, Impact, OHRQoL, Study, Duisterwinkel, Farnaz

Powered by WPeMatico

Early signs of heart problems linked to smaller brain volumes, suggests study

People who have early signs of heart problems may also have changes in brain health that can be early signs of dementia, such as loss of brain volume, according to a meta-analysis published on March 26, 2025, online in Neurology®, the medical journal of the American Academy of Neurology. The meta-analysis does not prove that early heart problems cause loss of brain cells; it only shows an association.

“This review shows that better heart health is associated with larger brain volumes, suggesting that the preservation of heart function could help maintain brain health and memory and thinking skills during the aging process,” said meta-analysis author Frank J. Wolters, MD, PhD, of Erasmus University Medical Center in Rotterdam, the Netherlands. “These results add to the importance of early detection and treatment of heart problems.”

The meta-analysis included seven studies from Europe and the United States with a total of 10,889 participants with an average age of 67. The studies measured early signs of heart problems, including systolic and diastolic dysfunction. Systolic dysfunction is when the left ventricle of the heart can’t contract normally and pump blood efficiently. Diastolic dysfunction is when the left ventricle does not relax properly between heartbeats and fill with blood. The studies also used MRI brain scans to measure brain volumes.

The meta-analysis found that people with moderate to severe systolic dysfunction were more likely to have a smaller total brain volume than people with normal systolic function. People with diastolic function problems also had a smaller total brain volume and smaller volume in the hippocampus area of the brain, which plays a role in memory.

“The meta-analysis shows that even mild diastolic dysfunction is associated with adverse brain health,” Wolters said. “Evaluating people who have heart problems-especially impaired diastolic function-for problems with memory and thinking skills could help us detect any cognitive decline early and start interventions.”

Wolters noted that additional studies are needed to investigate the relationship between heart health and brain health, particularly to link imaging findings to important health outcomes.

A limitation of the meta-analysis was that the majority of participants were white people, so the results cannot be generalized to more diverse populations.

Reference:

Yaqub, A., et al. (2025) Clinical and Imaging Markers of Cardiac Function and Brain Health. A Meta-Analysis of Community-Based Studies. Neurology. doi.org/10.1212/WNL.0000000000213421.

Powered by WPeMatico

Oral contraceptives and smoking impact steroid hormone levels in healthy adults: Study

Steroid hormone levels in healthy adults are influenced by oral contraceptives and smoking, as well as other lifestyle choices and factors such as biological sex and age, according to new research that has just been published in leading international journal Science Advances.

The objective of the research was to expand knowledge and understanding of steroid hormone levels, including corticoids and sex hormones, in healthy women and men over a broad age range. This is the first study to analyse such a large number of hormones in nearly 1,000 healthy people, filling a major gap in the knowledge of molecules that are important for our day-to-day well-being.

The work was conducted by members of the Milieu Interieur consortium and led by Dr Darragh Duffy (Institut Pasteur) and Dr Molly Ingersoll (Institut Pasteur and Institut Cochin (Inserm U1016, CNRS, Université Paris Cité). Dr Jamie Sugrue, a Trinity College Dublin graduate, now a Marie Curie-funded postdoctoral researcher at the Institut Pasteur, is the co-first author. Dr Sugrue also worked with Trinity’s Professor Cliona O’Farrelly to secure a Research Ireland Ulysses grant, which kickstarted the ongoing collaboration between Trinity researchers and the Pasteur and Milieu Interieur consortium teams.

The team involved in this current study found that hormone levels vary according to an individual’s age and sex, but that they are also associated with many other factors, such as genetics and common behaviours.

Notably, many steroid hormone levels, beyond sex hormones, are influenced by oral contraceptive use in women, while in men, smoking was associated with altered levels of nearly every steroid hormone measured.

Additionally, measurement of hormones in the same donors 10 years after the original visit showed that decreases in specific androgens were associated with diverse diseases in aging men, implying that these hormones – which are associated with physical characteristics, and supporting strong bones and red blood cell production – play a role in disease development.

This finding – among others – gives the team numerous avenues to pursue in future research.

Dr Sugrue said: “Even in healthy people, immune responses can vary dramatically. As a first step towards understanding how hormones impact immunity, we worked to understand how hormones themselves vary among people. Our study provides a significant resource for the research community, and generates many new hypotheses for further research. Our next steps will focus on understanding how variation in hormone levels contribute to differences in the immune response between people.”

“My current project is specifically focused on variation in antiviral immune responses in healthy people, and in many ways is a continuation of work that I started during my PhD with Prof. Cliona O’Farrelly at Trinity, where we worked on how antiviral immune system variation can confer resistance to hepatitis C virus infection. By incorporating the hormone measures into my current analysis I hope to uncover exciting new insights.”

Cliona O’Farrelly, Professor of Comparative Immunology in Trinity’s School of Biochemistry and Immunology, added: “If the COVID pandemic taught us anything it was how different all our immune systems are, and being part of the Milieu Interieur collaboration is giving us Trinity researchers a wonderful opportunity to study the molecular and genetic mechanisms responsible for these differences at scale.”

Co-first author, Dr Léa G Deltourbe, Institut Pasteur & Institut Cochin, added: “This study brings much needed data to a subject that is receiving a lot of interest in the mainstream news and on social media platforms, providing a strong basis for investigating the role of steroid hormones in health and disease, including the impact of endocrine disruptors, the link between stress and cortisol, and the role of sex hormones on our well-being.”

As one example, understanding the potential effects of the contraceptive pill on physical and mental health should lead to a better quality of life for women choosing to use this form of medication.

Reference:

Léa G. Deltourbe et al. ,Steroid hormone levels vary with sex, aging, lifestyle, and genetics.Sci. Adv.11,eadu6094(2025).DOI:10.1126/sciadv.adu6094

Powered by WPeMatico

New biomarkers could improve early detection, monitoring of kidney injury

Critical Path Institute® (C-Path) and Boston Medical Center (BMC) published results for six biomarkers that could improve the early and accurate detection of kidney injury, leading to both the development of safer medications and better health outcomes for all patients. The results leverage the collaborative expertise and investment of C-Path’s Predictive Safety Testing Consortium’s (PSTC) Nephrotoxicity Working Group, and the Clinical Evaluation and Qualification of Translational Kidney Safety Biomarkers Project, a public-private partnership managed collaboratively by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Kidney Safety Biomarker Project Team.

Drug-induced kidney injury, or nephrotoxicity, is a common complication in clinical medicine that happens when certain drugs at certain doses damage the kidneys. Nephrotoxicity can occur with multiple types of medicines, including anti-inflammatory, antibacterial, antiretroviral, or chemotherapeutic medicines and can lead to therapies being discontinued or restricted from patients. The findings from this collaboration were published recently in Clinical Pharmacology & Therapeutics. Sushrut Waikar, M.D., MPH, first author on the paper, said that these biomarkers may offer an approach to detect drug-induced kidney damage earlier than with existing standards for monitoring kidney health and can lead to more tolerable treatment options.

“Current biomarkers can be too slow at showing early signs of kidney injury,” said Waikar, Chief of Nephrology and Interim Medicine Chair at BMC. “These biomarkers, which can be measured in the urine, could help clinicians detect kidney damage within 24 hours of injury, enabling more timely monitoring during drug development and better treatment of patients who are at risk in clinical settings.”

The research team examined urinary levels of protein biomarkers in healthy volunteers and patients undergoing treatment for mesothelioma with a chemotherapy drug that is known to have toxic effects on the kidneys. This enabled the researchers to better understand how kidney function changes in response to injury.

The team assessed performance of six promising biomarkers to detect drug induced kidney injury with more sensitivity and specificity than traditional markers. Most of the assessed biomarkers are generated in the kidneys themselves in response to injury or inflammation. This enables detection of kidney injury quicker than current biomarkers, like serum creatinine, which can sometimes take several days to reach abnormal levels.

The research team now hopes to assess whether these biomarkers can be used more broadly to monitor kidney health in healthy volunteers during phase 1 clinical trials.

Earlier detection of kidney damage could allow clinicians to intervene sooner, reducing the risk of long-term damage and improving patient outcomes across all settings. “These biomarkers have the potential to make a real difference in how we monitor kidney health and manage patients at risk for kidney damage,” said Waikar, who is also the Norman G. Levinsky Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine. “We are hopeful that these findings will contribute to better strategies for preserving kidney function and improving patient care, as well as advancing drug development.”

“Collaboration is key to advancing new tools for drug safety and patient care,” said Nicholas King, PSTC’s Executive Director at C-Path. “By bringing together experts across sectors, we can assess and validate promising biomarkers, helping to accelerate their use in drug development. This study highlights how working together leads to meaningful progress in detecting and preventing kidney injury.”

Reference:

Sushrut S. Waikar, Robin Mogg, Amanda F. Baker, Gyorgy Frendl, Michael Topper, Scott Adler, Stefan Sultana, Runqi Zhao, Nicholas M. P. King, Steven P. Piccoli, John-Michael Sauer, Steve Hoffmann, Irene Nunes, Frank D. Sistare, Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury, Clinical Pharmacology & Therapeutics, https://doi.org/10.1002/cpt.3531.

Powered by WPeMatico

GERD Increases Risk of primary acquired nasolacrimal duct obstruction among elderly, confirms study

Researchers have found in a new study published in Eye that gastroesophageal reflux disease (GERD) significantly increases the risk of primary acquired nasolacrimal duct obstruction (PANDO), especially among women and older adults. The findings show that patients who have GERD face more than twofold risk of PANDO compared to those who do not have GERD. The study was conducted by Yung-Yu Chu and fellow researchers.

This large global study was predicated on over 157 million patient records worldwide in 18 different countries, and assessed the association between GERD and PANDO. This was a retrospective cohort study with data collected worldwide from the TriNetX Global Collaborative Network. Patients diagnosed with GERD between January 2004 and November 2024 were included in the study along with non GERD controls. To validate results, patients with prior or existing lacrimal passage disorders were excluded. The primary outcome was incidence of PANDO, with follow up of up to 20 years, for each patient and for a specified duration. Lastly, we used propensity score matching to balance baseline characteristics between the patients, and Cox proportional hazards regression to assess the relative risk.

Key Findings

  • After conducting propensity score matching, 876,330 total patients from both the GERD and control groups were included.

  • GERD patients were at an increased risk of developing PANDO (HR: 2.49; 95% CI: 2.18–2.85; p< 0.001).

  • The risk was higher in females (HR: 2.74; 95% CI: 2.32–3.24) and in older individuals aged ≥60 years (HR: 3.12; 95%CI: 2.59–3.74).

  • Comorbidities including diabetes, dyslipidemia, hypertension, ischemic heart disease, chronic kidney disease, and sinusitis increased the risk of GERD-related PANDO.

The underlying mechanism linking GERD to PANDO is not clear, although chronic inflammation may play a role. Acid reflux has been associated with inflammatory processes beyond the esophagus, which may lead to structural and functional changes in the nasolacrimal duct. Chronic exposure to gastric acid reflux may cause mucosal irritation, tissue remodeling, and fibrosis, thus increasing the risk of ductal obstruction. These findings highlight the need for a higher level of clinical awareness and interprofessional collaboration in the management of GERD patients, focusing on gastrointestinal health and eye health.

Reference:

Chu, YY., Ho, CH., Chen, YC. et al. Risk of primary acquired nasolacrimal duct obstruction among gastroesophageal reflux disease patients: a global population-based study. Eye (2025). https://doi.org/10.1038/s41433-025-03759-5

Powered by WPeMatico

Exclusive breastfeeding over longer period of duration reduces risk of developmental delays : JAMA

A new study published in the Journal of American Medical Association showed that exclusive breastfeeding for a longer period of time was linked to a lower risk of developmental delays and some neurodevelopmental disorders.

Early infancy is a critical period for addressing potentially changeable elements, such diet, in order to ensure healthy physical and cognitive development. The World Health Organization advises nursing exclusively for the first 6 months of life, then continuing to do so for up to 2 years or longer while consuming nutritious supplemental meals.

To maximize the potential of a child, it is essential to identify and address potentially changeable elements linked to healthy development. Confounding bias must be avoided, and differences in feeding methods must be taken into consideration when examining the results of child growth.

By linking routine developmental surveillance visits in national mother-child health clinics (MCHCs) and national insurance disability entitlements records, this study sought to estimate the relationship between breastfeeding and child development in both early-term to post term (37–42 weeks’ gestation) and late-preterm (35–36 weeks’ gestation) children.

Data from a nationwide network for routine child development surveillance in Israel that is connected to national social insurance financial entitlements for neurodevelopmental deficits were utilized in this retrospective cohort analysis. The participants were children born between January 2014 and December 2020, with at least one follow-up surveillance visit at the age of two or three and at least 35 weeks of gestation without significant morbidity. The delays in reaching developmental milestones and the identification of certain neurodevelopmental disorders were the main results.

Nearly, 20,642 (3.6%) of the 5,70,532 children (291,953 [51.2%] male) were preterm, 38,499 (6.7%) were tiny for gestational age, and 297,571 (52.1%) were breastfed for at least 6 months. When compared to children exposed to less than 6 months of nursing, those who were nursed for at least 6 months showed fewer delays in reaching linguistic and social or motor developmental goals.

Children who were nursed for at least 6 months out of 37,704 sibling pairs were less likely than their siblings who were breastfed for less than 6 months or not at all to exhibit milestone attainment delays or get a neurodevelopmental disorder diagnosis. Overall, persistent breastfeeding was linked to a decreased risk of developmental delays. 

Source: 

Goldshtein, I., Sadaka, Y., Amit, G., Kasir, N., Bourgeron, T., Warrier, V., Akiva, P., Avgil Tsadok, M., & Zimmerman, D. R. (2025). Breastfeeding duration and child development. JAMA Network Open, 8(3), e251540. https://doi.org/10.1001/jamanetworkopen.2025.1540

Powered by WPeMatico

Postpartum female preference for cooler temperatures linked to brain changes: Study

Mothers experience major metabolic adaptations during pregnancy and lactation to support the development and growth of the new life. Although many metabolic changes have been studied, body temperature regulation and environmental temperature preference during and after pregnancy remain poorly understood. Researchers at Baylor College of Medicine and collaborating institutions show in the journal Molecular Metabolism that postpartum female mice develop new environmental temperature preferences and reveal brain changes mediating these changes.

“In both humans and mice, body temperature increases during early pregnancy, drops to normal temperature during late pregnancy and then goes up again during lactation,” said co-corresponding author Dr. Chunmei Wang, assistant professor of pediatrics at USDA/ARS Children’s Nutrition Research Center at Baylor.

In this study, Wang and her colleagues investigated what changes occurred in the brain that mediated the new temperature preference. “We worked with mice and found that female mice prefer a cooler environment starting from late pregnancy and persisting in long-term postpartum,” Wang said. “For more than four weeks post-weaning female mice had a lower body temperature and preferred cooler environments; they lost their typical preference for warm environments (30 °C/86 °F) but still avoided cold environments (15 °C/59 °F).”

To identify the biological underpinnings of these changes, the researchers studied the preoptic area (POA), a brain region important for sensing and regulating body temperature. “We discovered that the change in temperature preference in postpartum female mice was associated with a significant decrease in a particular group of neurons, estrogen receptor alpha (ERα)-expressing neurons in the preoptic area of the brain (ERαPOA neurons),” Wang said.

Supporting this finding, the researchers found that virgin females in which the estrogen receptor alpha had been deleted in ERαPOA neurons also preferred lower temperatures and avoided warmer locations, mimicking postpartum females.

Looking closely into the ERαPOA neurons, the researchers found that these neurons vary in their ability to sense warm or cold temperatures – one group of ERαPOA neurons can directly respond to warmth, while another group responds to cooler temperatures. “Interestingly, compared to female mice that had not been pregnant, ERαPOA neurons of postpartum females had reduced response to warmth and an enhanced response to cold,” Wang said.

Together, the results support that the ability of ERαPOA neurons to sense warmth and cold is regulated by reproductive experience and leads to changes in temperature preferences that alter the animal’s warmth-seeking behavior. Currently, the researchers are exploring the function of each group of ERαPOA neurons on the regulation body temperature and thermal preference.

Reference:

Nan Zhang, Meng Yu, Qianru Zhao, Bing Feng, Yue Deng, Jonathan C. Bean, Qingzhuo Liu, Benjamin P. Eappen, Yang He, Kristine M. Conde, Hailan Liu, Yongjie Yang, Longlong Tu, Mengjie Wang, Yongxiang Li, Na Yin, Hesong Liu, Junying Han, Darah Ave Threat, Nathan Xu, Taylor Smiley, Pingwen Xu, Lulu Chen, Tianshu Zeng, Yanlin He, Chunmei Wang, Altered thermal preference by preoptic estrogen receptor alpha neurons in postpartum females, Molecular Metabolism, https://doi.org/10.1016/j.molmet.2025.102108.

Powered by WPeMatico

Cannabis Use Before or During Pregnancy Linked to Increased Risk of Nausea and Vomiting: Study Finds

USA: A recent study published in Obstetrics & Gynecology has found a significant association between cannabis use before and during pregnancy and an increased likelihood of experiencing nausea and vomiting in pregnancy (NVP). The highest risk was observed among individuals who used cannabis daily, emphasizing the need for awareness and alternative medical approaches for managing NVP.

Researchers found that both mild and severe NVP were more common among individuals who consumed cannabis before or during early pregnancy. Notably, those who used cannabis daily had the highest odds of experiencing these symptoms, highlighting a potential dose-dependent relationship.

The cross-sectional study by Kelly C. Young-Wolff, PhD, MPH, Research Scientist, Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, and colleagues examined the link between cannabis use before and during pregnancy and first-trimester nausea and vomiting (NVP) by analyzing data from 356,343 pregnancies within a major healthcare system between 2011 and 2022.

Key Findings:

  • Cannabis Use Before and During Pregnancy:
    • 11.3% used cannabis before pregnancy (2.7% daily, 2.4% weekly, 6.3% monthly or less).
    • 6.5% used cannabis during pregnancy (0.7% daily, 0.7% weekly, 1.4% monthly or less, 3.7% detected via toxicology without self-reporting).
  • Prevalence of Nausea and Vomiting in Pregnancy (NVP):
    • 16.0% experienced mild NVP.
    • 3.6% were diagnosed with severe NVP.
  • Impact of Cannabis Use Before Pregnancy on NVP:
    • Daily use increased the odds of mild NVP by 68% and severe NVP by 161%.
    • Weekly use increased the odds of mild NVP by 26% and severe NVP by 73%.
  • Impact of Cannabis Use During Pregnancy on NVP:
    • Daily use increased the odds of mild NVP by 97% and severe NVP by 280%.
    • Weekly use increased the odds of mild NVP by 85% and severe NVP by 187%.

The study found a strong link between cannabis use before or during early pregnancy and an increased risk of nausea and vomiting in the first trimester. Women who used cannabis, especially daily users, had higher chances of experiencing both mild and severe nausea and vomiting. This association could be due to cannabis withdrawal or cannabinoid hyperemesis syndrome.

“These findings highlight the importance of patient education on the potential risks of cannabis use during pregnancy and the need for safe, medically appropriate treatments for managing nausea and vomiting in pregnancy,” the authors concluded.

Reference:

Young-Wolff, Kelly C. PhD, MPH; Chi, Felicia W. MPH; Campbell, Cynthia I. PhD, MPH; Alexeeff, Stacey E. PhD; Ansley, Deborah MD; Vanderziel, Alyssa PhD; Lapham, Gwen T. PhD, MPH, MSW. Frequency of Preconception and Prenatal Cannabis Use and Nausea and Vomiting in Pregnancy. Obstetrics & Gynecology ():10.1097/AOG.0000000000005884, March 13, 2025. | DOI: 10.1097/AOG.0000000000005884

Powered by WPeMatico